Replies to post #16519 on Positron Corporation (POSC)

[bpatient]

No one knows for certain when the share price will reflect what appears to be on the horizon for Positron (based on news releases). Reported revenue on the next 10Q from sales of radiopharmaceuticals would be a good start (later this month). In my opinion, medical imaging is one of the key factors in reducing healthcare costs. Prevention is always less costly, and this company seems to have a good strategy to support the medical imaging market.